Cardiovascular disease test kit Fimics lncRNA panel

Whole Blood Genomicwhole bloodtissue

Cardiovascular disorders such as heart failure are leading causes of mortality. Patient stratification via identification of novel biomarkers could improve management of cardiovascular diseases of complex etiologies. Long-noncoding RNAs (lncRNAs) are highly tissue-specific in nature and have emerged as important biomarkers in human diseases. FIMICS is a proprietary innovative in vitro diagnostic (IVD) test designed and developed by Firalis for diagnostic applications in cardiac patients. FIMICs is a targeted sequencing (TS)-Next Generation Sequencing (NGS) test for the quantitative determination of long non-coding RNAs in human blood. The FIMICs panel of cardiac-enriched lncRNAs can be used, in conjunction with the clinical findings and other diagnostic tools, as an aid for subjects’ identification with risk of heart failure with reduced ejection fraction (HFrEF) or heart failure with preserved ejection fraction (HFpEF) following Acute Myocardial Infarction (AMI) treated by percutaneous coronary intervention (PCI).